Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study

Background: Multimorbidity, i.e. two or more non-communicable diseases (NCDs), has been associated with venous thromboembolism (VTE), but whether multimorbidity is a predictor for incident VTE is unknown. Aims: To examine the associations between multimorbidity and its severity with risk of incident...

Full description

Saved in:
Bibliographic Details
Main Authors: Jonatan Ahrén, MirNabi Pirouzifard, Björn Holmquist, Jan Sundquist, Kristina Sundquist, Bengt Zöller
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Thrombosis Update
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S266657272500001X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540386110734336
author Jonatan Ahrén
MirNabi Pirouzifard
Björn Holmquist
Jan Sundquist
Kristina Sundquist
Bengt Zöller
author_facet Jonatan Ahrén
MirNabi Pirouzifard
Björn Holmquist
Jan Sundquist
Kristina Sundquist
Bengt Zöller
author_sort Jonatan Ahrén
collection DOAJ
description Background: Multimorbidity, i.e. two or more non-communicable diseases (NCDs), has been associated with venous thromboembolism (VTE), but whether multimorbidity is a predictor for incident VTE is unknown. Aims: To examine the associations between multimorbidity and its severity with risk of incident VTE, and examine the association between nine different disease clusters and incident VTE. Methods: A cohort study using landmark analysis of 2,694,442 individuals. Swedish national registers were linked and three landmarks (L1, L2, L3), i.e. baselines, were created with 14-, nine- and four-year follow-up times, respectively. Two or more NCDs defined multimorbidity and ≥5 marked multimorbidity severity. A hazard ratio (HR) with 95 % confidence interval (CI) for VTE was calculated and adjusted for sex, education and year of birth. Death and emigration were treated as competing events. Results: A total of 2,694,442 individuals were included. Multimorbidity was associated with incident VTE in all three analyzed landmarks: adjusted HR for VTE was 2.47 (95%CI 2.24–2.72) for L1, HR was 2.23 (95%CI 2.11–2.36) for L2, and HR was 2.16 (95%CI 2.03–2.29) for L3. HR increased with multimorbidity severity. For instance, HRs for multimorbidity with five or more NCDs was 4.29 (95%CI 2.53–7.28) in L1 analysis, 4.45 (95%CI 3.64–5.45) in L2 analysis and 4.83 (95%CI 4.20–5.55) in L3 analysis. Moreover, seven of nine different multimorbidity disease clusters were predictors for VTE. Conclusion: This study demonstrated proof-of-concept that multimorbidity is a novel dose-graded predictor for VTE. Further studies will determine the usefulness of multimorbidity for VTE prediction in different clinical settings.
format Article
id doaj-art-4d18ef5f1f3f4c059cb067300eab4340
institution Kabale University
issn 2666-5727
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Thrombosis Update
spelling doaj-art-4d18ef5f1f3f4c059cb067300eab43402025-02-05T04:32:41ZengElsevierThrombosis Update2666-57272025-03-0118100198Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept studyJonatan Ahrén0MirNabi Pirouzifard1Björn Holmquist2Jan Sundquist3Kristina Sundquist4Bengt Zöller5Center for Primary Health Care Research, Lund University/Region Skåne, 205 02, Malmö, Sweden; University Clinic Primary Care Skåne, Region Skåne, Sweden; Corresponding author. Center for Primary Health Care Research, CRC, Building 28, Floor 11, Jan Waldenströms gata 35, Skåne University Hospital, S-205 02, Malmö, Sweden.Center for Primary Health Care Research, Lund University/Region Skåne, 205 02, Malmö, Sweden; University Clinic Primary Care Skåne, Region Skåne, SwedenDepartment of Statistics, Lund University, 220 07, Lund, SwedenCenter for Primary Health Care Research, Lund University/Region Skåne, 205 02, Malmö, Sweden; University Clinic Primary Care Skåne, Region Skåne, SwedenCenter for Primary Health Care Research, Lund University/Region Skåne, 205 02, Malmö, Sweden; University Clinic Primary Care Skåne, Region Skåne, SwedenCenter for Primary Health Care Research, Lund University/Region Skåne, 205 02, Malmö, Sweden; University Clinic Primary Care Skåne, Region Skåne, SwedenBackground: Multimorbidity, i.e. two or more non-communicable diseases (NCDs), has been associated with venous thromboembolism (VTE), but whether multimorbidity is a predictor for incident VTE is unknown. Aims: To examine the associations between multimorbidity and its severity with risk of incident VTE, and examine the association between nine different disease clusters and incident VTE. Methods: A cohort study using landmark analysis of 2,694,442 individuals. Swedish national registers were linked and three landmarks (L1, L2, L3), i.e. baselines, were created with 14-, nine- and four-year follow-up times, respectively. Two or more NCDs defined multimorbidity and ≥5 marked multimorbidity severity. A hazard ratio (HR) with 95 % confidence interval (CI) for VTE was calculated and adjusted for sex, education and year of birth. Death and emigration were treated as competing events. Results: A total of 2,694,442 individuals were included. Multimorbidity was associated with incident VTE in all three analyzed landmarks: adjusted HR for VTE was 2.47 (95%CI 2.24–2.72) for L1, HR was 2.23 (95%CI 2.11–2.36) for L2, and HR was 2.16 (95%CI 2.03–2.29) for L3. HR increased with multimorbidity severity. For instance, HRs for multimorbidity with five or more NCDs was 4.29 (95%CI 2.53–7.28) in L1 analysis, 4.45 (95%CI 3.64–5.45) in L2 analysis and 4.83 (95%CI 4.20–5.55) in L3 analysis. Moreover, seven of nine different multimorbidity disease clusters were predictors for VTE. Conclusion: This study demonstrated proof-of-concept that multimorbidity is a novel dose-graded predictor for VTE. Further studies will determine the usefulness of multimorbidity for VTE prediction in different clinical settings.http://www.sciencedirect.com/science/article/pii/S266657272500001XEpidemiologyMedicineMultimorbidityPublic healthVenous thromboembolism
spellingShingle Jonatan Ahrén
MirNabi Pirouzifard
Björn Holmquist
Jan Sundquist
Kristina Sundquist
Bengt Zöller
Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
Thrombosis Update
Epidemiology
Medicine
Multimorbidity
Public health
Venous thromboembolism
title Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
title_full Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
title_fullStr Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
title_full_unstemmed Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
title_short Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
title_sort multimorbidity is associated with risk of incident venous thromboembolism a nationwide proof of concept study
topic Epidemiology
Medicine
Multimorbidity
Public health
Venous thromboembolism
url http://www.sciencedirect.com/science/article/pii/S266657272500001X
work_keys_str_mv AT jonatanahren multimorbidityisassociatedwithriskofincidentvenousthromboembolismanationwideproofofconceptstudy
AT mirnabipirouzifard multimorbidityisassociatedwithriskofincidentvenousthromboembolismanationwideproofofconceptstudy
AT bjornholmquist multimorbidityisassociatedwithriskofincidentvenousthromboembolismanationwideproofofconceptstudy
AT jansundquist multimorbidityisassociatedwithriskofincidentvenousthromboembolismanationwideproofofconceptstudy
AT kristinasundquist multimorbidityisassociatedwithriskofincidentvenousthromboembolismanationwideproofofconceptstudy
AT bengtzoller multimorbidityisassociatedwithriskofincidentvenousthromboembolismanationwideproofofconceptstudy